Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Primary Target

vasoconstriction

30

Histamine H1 receptor

316

Dopamine D2 receptor

311

DNA

282

Serotonin 2a (5-HT2a) receptor

237

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved OTC

29

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

30

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1903

29

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Itching

29

Otitis

29

Arteriosclerosis obliterans

1

Buerger's disease

1

Chilblains

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Curative

30

Primary

29

Palliative

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Burow, K.A.

29

Yoshitomi Pharmaceutical Industries

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

30

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

30

FDA UNII

30

PUBCHEM

30

EPA CompTox

24

DAILYMED

19

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

DERMATOLOGICALS

1

SENSORY ORGANS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTI-ACNE PREPARATIONS

1

OPHTHALMOLOGICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTI-ACNE PREPARATIONS FOR TOPICAL USE

1

OTHER OPHTHALMOLOGICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other anti-acne preparations for topical use

1

Other ophthalmologicals

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

28

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 30 results

First page disabled
Previous page disabled
1
Next page
Next page

ALUMINUM CATION

3XHB1D032B

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

HEPRONICATE

E4RK86FAVR

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Arteriosclerosis obliterans

Raynaud's disease

Buerger's disease

Hepronicate is a nicotinic acid derivative, developed and used in Japan under the name Megrin for the treatment of peripheral circulatory disorders. The therapeutic effect of the drug is explained by its vasodilation properties.

ALUMINUM SULFATE

34S289N54E

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

ALUMINUM SODIUM SULFATE

0CM6A697VV

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

AMMONIUM TETRACHLOROALUMINATE

9J0845B23P

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

ALUMINUM HYDROXIDE SULFATE (AL(OH)(SO4))

9QO62ZS7VO

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

ALUMINUM BROMIDE

IY20HBK5LK

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

TETRAALUMINUM TRICHLORIDE NONAHYDROXIDE

C7G8ACS82V

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

ALUMINUM IODIDE

L903Z8J9VR

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

ALUMINUM IODIDE HEXAHYDRATE

VWS43EUO9V

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1903

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

vasoconstriction

Conditions:

Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum su...

lfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate. The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.

Showing 1 - 10 of 30 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1